CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.
By Suzanne King The Beacon A year ago this week, 27 pharmacists walked off their jobs in and around Kansas City to protest ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback